newsfilter
← Latest News
Business Wire·

AlloVir Announces Pricing of Public Offering of Common Stock

AlloVir, Inc. (NASDAQ:ALVR), a late clinical-stage cell therapy company, today announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $3.75 per